ey0019.5-1 | Novel treatments for rare skeletal disorders | ESPEYB19
IW Song
, SC Nagamani
, D Nguyen
, I Grafe
, VR Sutton
, FH Gannon
, E Munivez
, MM Jiang
, A Tran
, M Wallace
, P Esposito
, S Musaad
, E Strudthoff
, S McGuire
, M Thornton
, V Shenava
, S Rosenfeld
, S Huang
, R Shypailo
, E Orwoll
, B Lee
J Clin Invest. 2022 Apr 1;132(7):e152571. doi: 10.1172/JCI152571.Abstract: https://pubmed-ncbi-nlm-nih-gov.proxy.kib.ki.se/35113812/In brief: Currently, there is no disease-specific therapy for osteogenesis imperfecta (OI) where most children, of all forms of OI, with significant fracture history, are managed by bisphosphonates...